BMPR2 and HIV infectious disease: Although BMPR2 mutations are not always prevalent in patients, the upstream targets may still be affected by certain cellular or molecular processes such as microRNA (miRNA) regulation [17] or viral HIV infection [18,19], all leading to lower BMPR2 protein levels and subsequent development of a pathophysiological response [20,21].